Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA surveillance division director

Executive Summary

Solomon Iyasu is named permanent FDA Director of the Division of Surveillance, Research & Communication Support, the agency announces Aug. 14. Iyasu, whose responsibilities include directing epidemiologic data resources and drug use analysis teams as well as overseeing patient information and research and contracts teams, previously held the position in an acting capacity. Iyasu joined FDA in 2002 and has served as acting deputy director of the division of pediatric drug development. DSCRCS has had acting directors since Gerald Dal Pan was elevated to Office of Surveillance and Epidemiology Director (1"The Pink Sheet" Oct. 24, 2005, p. 3)...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

PS047491

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel